dalteparin has been researched along with Amputation, Traumatic in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Amputation, Traumatic: Loss of a limb or other bodily appendage by accidental injury.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Loisel, F | 1 |
| Pauchot, J | 1 |
| Gasse, N | 1 |
| Meresse, T | 1 |
| Rochet, S | 1 |
| Tropet, Y | 1 |
| Obert, L | 1 |
1 other study available for dalteparin and Amputation, Traumatic
| Article | Year |
|---|---|
[Addition of antithrombosis in situ in the case of digital replantation: preliminary prospective study of 13 cases].
Topics: Adolescent; Adult; Aged; Amputation, Traumatic; Anastomosis, Surgical; Anticoagulants; Aspirin; Drug | 2010 |